HLA Corp explores Hong Kong H-share listing for global expansion

HLA Corp announced its board of directors approved preparatory work for an overseas H-share issuance and listing on The Stock Exchange of Hong Kong Limited. This strategic move, approved on September 8, 2025, aims to deepen the company's global strategy, accelerate international business development, enhance its international brand image, and diversify its capital operation platform.

Management is authorized to discuss specific implementation with relevant intermediaries, though the details of the H-share listing are yet to be finalized. This initiative is expected to strengthen HLA Corp's capital base and support its high-quality growth.

HLA Corp will adhere to regulatory requirements from the Shanghai Stock Exchange and the China Securities Regulatory Commission, and will proceed with necessary board and shareholder approvals. The company cautions investors that the H-share listing is subject to significant uncertainties, including regulatory approvals and market conditions.